TEVA-Losartan Product Recall (2021-05-25)
- Starting date:
- May 25, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-75687
Last updated:
2021-05-31
Summary
-
Product:
- TEVA-Losartan 50 mg Tablet
- TEVA-Losartan 25 mg Tablet
- TEVA-Losartan 100 mg Tablet
- TEVA-Losartan 50 mg Tablet
- TEVA-Losartan 25 mg Tablet
- TEVA-Losartan 100 mg Tablet
Reason
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.
Depth of distribution
Retailers
Affected products
-
TEVA-Losartan 50 mg Tablet
DIN, NPN, DIN-HIM
DIN 02357968
Dosage form
Tablet
Strength
Losartan Potassium 50 mg
Lot or serial number
1040120, 1030120, 1040419, 1050419, 1060419, 1070419, 1080918, 1090918, 1090819, 1100819, 1101018, 1110819, 1111018, 1121018, 1130819, 1180919, 1010120, 1030218, 1080419, 1120819, 1141018
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
B. TEVA-Losartan 25 mg Tablet
DIN, NPN, DIN-HIM
DIN 02380838
Dosage form
Tablet
Strength
Losartan Potassium 25 mg
Lot or serial number
0010219, 0020419, 0030419, 0031018, 0040120, 0040919, 0050620, 0050919, 0060620, 0070620, 0010120, 0020120
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
C. TEVA-Losartan 100 mg Tablet
DIN, NPN, DIN-HIM
DIN 02357976
Dosage form
Tablet
Strength
Losartan Potassium 100 mg
Lot or serial number
2010219, 2010420, 2020219, 2020420, 2030420, 2040219, 2060419, 2080619, 2080918, 2091018, 2101018, 2161119, 2171119, 2030218, 2070419, 2140919, 2181119, 2191119
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA